Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absence, accredited, ADC, adenocarcinoma, ADR, affirmed, aforementioned, aim, alcoholic, AML, anaplastic, Ann, Anokion, antidilutive, aprpoved, Ascend, atezolizumab, atrioventricular, banc, BCBSA, BCBSM, begun, bereavement, Black, Blue, bolstered, Boudry, Bravo, Breyanzi, Bristol, broader, BSC, carboplatin, cardiomyopathy, career, carefully, causation, certified, chemoradiation, chemoradiotherapy, child, Cigna, cisplatin, clause, clear, CMMoL, College, Color, commitee, commuter, compel, conspiracy, Cooperation, copay, corticosteroid, count, creation, cultivating, curative, cytarabine, cytokine, DAYBREAK, dental, deplete, derica, deucravacitinib, discourage, discouraging, discretionary, distancing, DMC, doctrine, doubling, downturn, Dragonfly, drawn, dynamic, dynamically, economy, elder, Elizabeth, embody, empower, en, endoscopic, enlarged, epidermal, equated, exacerbate, exciting, expenditure, family, feasibility, feedback, filtration, forum, fullest, gastroesophageal, gender, Genitourinary, glomerular, HCSC, heard, HHS, home, HPI, hypertrophic, hypomethylating, iberdomide, ICE, idecabtagene, IDHENTIFY, immunodeficiency, inapplicable, incentivize, induction, ineligible, influx, inspire, instance, intervention, isocitrate, JAK, junction, Kaposi, KarMMa, knowledge, lab, Latino, leader, learn, learning, led, legislature, lentiviral, lessen, lessor, lever, Living, lt, Lupin, lymphoblastic, Malignant, mavacamten, metastic, methyltransferase, MGMT, MHLW, military, Mily, Minnesota, mirror, mosaic, multiforme, myelomonocytic, MyoKardia, Negro, neoplasm, NMPA, noninfringement, nurturing, obstructive, onset, onsite, Ontario, Onureg, opted, Organisation, organizational, ORR, outpatient, Overnight, Pan, pandemic, parent, parental, parity, PASI, paula, pausing, PBRG, pemetrexed, pet, pharmacy, phishing, pioneering, Pleural, POETYK, Powell, precision, prejudgment, preliminarily, pretreated, PRIDE, prolonged, Prospanica, published, pulmonary, Quebec, recharge, recommenced, reconsider, recovered, recruiting, relieve, remission, remote, renegotiate, renegotiated, representation, residual, restarted, resumed, resumption, retiree, reverted, reward, rice, RMS, RNA, ruxolitinib, sarcoma, scarcity, Schwab, score, Septal, shape, shelter, Shield, sick, signature, Singapore, slowdown, sNDA, SOFR, solvency, soul, sPGA, spleen, splenomegaly, static, statue, steering, stimulating, stretch, stringent, strive, subgroup, sudden, surrogate, survey, switch, switching, Symposium, tangible, Tecentriq, tenure, thereunder, thriving, thrombocythaemia, Tolerance, training, transient, translocation, travel, traveling, TriPhase, True, tuition, Twelfth, UC, UHS, unblinded, undertook, unemployment, unified, unsatisfactory, unused, unyielding, USD, vacancy, vacation, vaccine, validly, valuable, vector, venue, vicleucel, vision, volunteer, warehousing, wider, withdrew, workday, workplace, worse, writing, xii, xiii, xiv, Zeposia, zone
Removed:
acceptance, accessing, adnectin, age, agonist, analgesic, ASEAN, asymptomatic, autoimmunity, bad, Belgium, bleeding, build, buyer, cabiralizumab, Cardioxyl, Connecticut, constitute, continuously, CytomX, depreciated, dMMR, dual, Duchenne, Dystrophy, Elicker, enactment, expecting, expressly, false, favor, financed, fragment, graduate, Gulf, IFM, India, infused, innate, intermediate, Investor, iPierian, John, lymph, minimally, minimize, modulate, Muscular, nominated, Palsy, passed, Perfalgan, postgraduate, powder, Prime, Probody, profession, prospectively, rated, realign, Redwood, revoked, Secretary, Silver, simplify, step, STING, stroke, subcutaneously, substitution, summarize, Supranuclear, symptomatic, transitional, undergone, uniquely, ViiV, vitamin, VTE, Wallingford
Filing tables
Filing exhibits
- 10-K Annual report
- 4 Description of Bristol-myers Squibb Companys Securities
- 10 Extension Notice for Revolving Credit Facility Dated September 29, 2011
- 10 Extension Notice for Revolving Credit Facility Agreement Dated July 30, 2012
- 10 Amendment to Revolving Credit Facility Dated September 29, 2011
- 10 Amendment to Revolving Credit Facility Dated July 30, 2012
- 10 Psu Award Agreement Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 5-YEAR Vesting Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 4-YEAR Vesting Under the 2012 Stock Award and Incentive Plan
- 10 Rsu Agreement with 2-YEAR Cliff Vesting Under the 2012 Stock Award and Incentive
- 10 Rsu Agreement with 1-YEAR Cliff Vesting Under the 2012 Stock Award and Incentive
- 10 Msu Agreement Under the 2012 Stock Award and Incentive Plan
- 10 BMS Benefit Equalization Plan - Retirement Income Plan
- 10 BMS Benefit Equalization Plan - Savings and Investment Program
- 10 Senior Executive Severance Plan
- 21 Exhibit 21
- 23 Exhibit 23
- 31 Exhibit 31.A
- 31 Exhibit 31.B
- 32 Exhibit 32.A
- 32 Exhibit 32.B
- Download Excel data file
- View Excel data file
Related press release
Associated BMY transcripts
BMY similar filings
Filing view
External links
EXHIBIT 10o
Citibank, N.A., as Administrative Agent
388 Greenwich Street
New York, New York 10013
Attention: Richard Rivera
January 4, 2021
Ladies and Gentlemen:
Re: Extension of Maturity Date
Reference is made to the Five Year Competitive Advance and Revolving Credit Facility Agreement, dated as of September 29, 2011 (as amended, supplemented or otherwise modified prior to the date hereof, the “Credit Agreement”) among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), the Borrowing Subsidiaries, the lenders parties thereto (the “Lenders”), certain Agents, Citibank , N.A., as an Administrative Agent, and JPMorgan Chase Bank, N.A., as an Administrative Agent. Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.
Pursuant to Section 2.5 of the Credit Agreement, the Company hereby requests that the Lenders extend the Maturity Date in effect on the date hereof (i.e., September 29, 2023) such that the extended Maturity Date under the Credit Agreement will be September 29, 2024. This letter shall constitute an “Extension Letter” as referred to in Section 2.5 of the Credit Agreement.
Very truly yours, | |||||
BRISTOL-MYERS SQUIBB COMPANY | |||||
By: | /s/ Jeffrey Galik | ||||
Name: Jeffrey Galik | |||||
Title: Senior Vice President and Treasurer |